AQP5 and breast cancer: Additionally, overexpression of AQP5 was associated with worse outcomes in early breast cancer patients regardless of tumour type and stage, suggesting it as an independent prognostic marker of survival, particularly in hormone receptor-positive patients who underwent curative surgery [100].